
Celularity Inc
CELUNasdaqCIK 1752828HealthcareFiscal year ends Dec 31
Reports and events: 186 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-04-2317:15 ET | 8-K | 3.01 Delisting notice | 0001641172-25-005884 |
| 2025-03-2116:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011156 |
| 2025-02-2409:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-007986 |
| 2025-02-1808:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-007097 |
| 2025-02-1306:20 ET | S-1/A | Registration statement, amended | 0001493152-25-006219 |
| 2025-01-3017:31 ET | S-1 | Registration statement | 0001493152-25-004313 |
| 2025-01-2816:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-002203 |
| 2025-01-2709:00 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-25-003722 |
| 2025-01-2417:17 ET | 8-K | 1.02 Termination of a material agreement | 0001493152-25-003635 |
| 2025-01-0317:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-000294 |
| 2024-12-2008:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-050885 |
| 2024-12-1921:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-24-049987 |
| 2024-12-0619:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-133799 |
| 2024-12-0217:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-048330 |
| 2024-11-2921:08 ET | 8-K | 3.01 Delisting notice | 0001493152-24-048082 |
| 2024-11-1916:15 ET | DEF 14A | Proxy statementPeriod 2024-10-19 | 0001493152-24-046819 |
| 2024-11-0816:30 ET | 8-K | 8.01 Other events | 0001493152-24-044292 |
| 2024-11-0708:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-043924 |
| 2024-11-0717:33 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-122493 |
| 2024-10-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-042525 |
| 2024-10-2107:24 ET | 8-K | 3.01 Delisting notice | 0001493152-24-041706 |
| 2024-10-1617:25 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-115082 |
| 2024-10-1617:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-041330 |
| 2024-09-1317:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-036234 |
| 2024-08-2817:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034216 |
| 2024-08-2317:15 ET | 8-K | 3.01 Delisting notice | 0001493152-24-033763 |
| 2024-08-0517:15 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-030288 |
| 2024-07-3016:26 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-087886 |
| 2024-05-2417:15 ET | 8-K | 3.01 Delisting notice | 0001493152-24-021404 |
| 2024-05-2109:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-020832 |
| 2024-04-2206:05 ET | 8-K | 3.01 Delisting notice | 0001493152-24-015455 |
| 2024-03-1517:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-013586 |
| 2024-03-1517:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-010134 |
| 2024-02-2617:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-007848 |
| 2024-02-2209:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-007505 |
| 2024-02-1216:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-005900 |
| 2024-02-0206:01 ET | DEF 14A | Proxy statementPeriod 2024-02-02 | 0001493152-24-004649 |
| 2024-01-1717:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-002583 |
| 2024-01-1716:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-005029 |
| 2024-01-0916:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-003387 |
| 2024-01-0321:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-24-000474 |
| 2023-12-2916:47 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-073894 |
| 2023-11-2413:46 ET | 8-K | 3.01 Delisting notice | 0001193125-23-282722 |
| 2023-09-1909:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000950170-23-048663 |
| 2023-09-0716:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-047017 |
| 2023-08-2909:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-044896 |
| 2023-08-2516:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-221469 |
| 2023-08-1417:24 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042544 |
| 2023-08-0416:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-038577 |
| 2023-07-2816:27 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-197738 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.